Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Afr Health Sci ; 7(1): 18-24, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17604521

RESUMO

BACKGROUND: Chlamydia infections have been reported to cause silent infections in communities which becomes endemic and could remain unnoticed for a very long time. In most parts of Nigeria these organisms are not screened for, and hence relative information about frequencies of the organisms are sparse. METHOD: Five hundred and sixty five blood samples and ten umbilical cord fluids were collected from various patients attending clinics in South Eastern Nigeria and were screened for Chlamydia Complement Fixing Antibody (CCFA). Endocervical swabs and urethral discharges or swabs were collected from patients whose serum was positive and were cultured into embryonic eggs which was later observed, harvested and stained using the Romanowsky-Giemsa staining techniques. The positive sera were further confirmed by distinguishing the species of Chlamydia using the monoclonal antibody spot test kit. RESULT: Of the five hundred and sixty five (565) samples collected only three hundred and forty were positive to CCFA, of which 141 were males and 204 females. From the cultured samples 230 were positive for Chlamydia trachomatis and 99 positive to Chlamydia pneumoniae. Statistical analysis using the student's t test at 95% confidence interval shows that there was no significant difference between the number of females and males that presented themselves for screening. CONCLUSION: Proper screening of patients to include Chlamydia should be encouraged at all levels of medical diagnosis in the country so as to proffer treatment. Otherwise the infection will remain a "silent epidemic", as is the case currently.


Assuntos
Infecções por Chlamydia/epidemiologia , Infecções por Chlamydia/prevenção & controle , Chlamydia trachomatis/isolamento & purificação , Surtos de Doenças/prevenção & controle , Programas de Rastreamento , Adolescente , Distribuição por Idade , Criança , Testes de Fixação de Complemento , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Nigéria/epidemiologia , Gravidez , Kit de Reagentes para Diagnóstico , Sorotipagem , Distribuição por Sexo
2.
Trop Doct ; 35(1): 16-7, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15712534

RESUMO

Of the 876 rodents caught in different parts of Ekpoma, Nigeria, and environs, 218 were Mastomys natalensis, while 658 were other rodents. Of the 218 M. natalensis caught, 102 (46.79%) were positive for complement fixing antibody to Lassa virus.


Assuntos
Febre Lassa/sangue , Vírus Lassa , Roedores/virologia , Animais , Anticorpos Antivirais/sangue , Testes de Fixação de Complemento , Nigéria , Ratos , Estudos Soroepidemiológicos
3.
West Afr J Med ; 21(2): 124-7, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12403034

RESUMO

The antibiogram and Beta-lactamase of 73 isolates of Staphylococcus aureus from 235 different human clinical specimens were determined using standard procedures. These various clinical specimens were got from teaching hospitals and some private hospitals in Edo State. The results of the antibiogram showed 100% susceptibiity to Vancomycin, 78.1% to Gentamicin, 71.3% to Chloramphenicol, 69.8% to Erythromycin and 61.6% to Cloxacillin. The results of the beta-lactamase detection showed that 84.1% of the isolates were penicillinase positive, which probably accounted for the 100% resistance obtained for both Ampicillin and Penicillin. This thus suggests that clinicians should enlighten patients on the consequences of indiscriminate use of Penicillin and other antimicrobial agents.


Assuntos
Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/isolamento & purificação , beta-Lactamases , Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Resistência Microbiana a Medicamentos , Uso de Medicamentos , Hospitais de Ensino , Hospitais Universitários , Humanos , Incidência , Testes de Sensibilidade Microbiana , Nigéria/epidemiologia , Seleção de Pacientes , Guias de Prática Clínica como Assunto , Prevalência , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/epidemiologia , Staphylococcus aureus/classificação , Staphylococcus aureus/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA